KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to -$20.0 million.

  • Elevance Health's Gains from Investment Securities fell 21111.11% to -$20.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.0 million, marking a year-over-year decrease of 7419.35%. This contributed to the annual value of $32.0 million for FY2025, which is 7419.35% down from last year.
  • Per Elevance Health's latest filing, its Gains from Investment Securities stood at -$20.0 million for Q4 2025, which was down 21111.11% from $12.0 million recorded in Q3 2025.
  • Elevance Health's 5-year Gains from Investment Securities high stood at $123.0 million for Q1 2025, and its period low was -$83.0 million during Q2 2025.
  • Over the past 5 years, Elevance Health's median Gains from Investment Securities value was $7.0 million (recorded in 2021), while the average stood at $26.7 million.
  • In the last 5 years, Elevance Health's Gains from Investment Securities skyrocketed by 280000.0% in 2022 and then tumbled by 21111.11% in 2025.
  • Quarter analysis of 5 years shows Elevance Health's Gains from Investment Securities stood at $1.0 million in 2021, then soared by 2800.0% to $29.0 million in 2022, then tumbled by 89.66% to $3.0 million in 2023, then skyrocketed by 500.0% to $18.0 million in 2024, then tumbled by 211.11% to -$20.0 million in 2025.
  • Its Gains from Investment Securities stands at -$20.0 million for Q4 2025, versus $12.0 million for Q3 2025 and -$83.0 million for Q2 2025.